Union Health Minister Harsh Vardhan has given great relief to the people waiting for the Corona vaccine in the country. Harshvardhan said today that the coronavirus vaccine will be available in India early next year from more than one source. He made this statement during a meeting with the Group of Ministers. News agency ANI quoted Harsh Vardhan as saying, “We are expecting that we will have vaccines available from more than one source in the country early next year. Our expert group plans on how to start the delivery of the vaccine in the country.”
We’re expecting that early next year we should have vaccine in the country from maybe more than one source. Our expert groups are formulating strategies to plan on how to roll out the distribution of the vaccine in the country: Union Health Min during Group of Ministers meeting pic.twitter.com/M2G0QzNFxG
— ANI (@ANI) October 13, 2020ADVERTISEMENT
Coronavirus figures include 8,38,729 active cases
Recently, the Union Minister said that by the first quarter of 2021, we are likely to have a Coronavirus Vaccine available. According to data released by the Union Ministry of Health, India’s Covid-19 tally reached 71,75,881 today with 55,342 new cases and 706 deaths in the last 24 hours. Coronavirus figures include 8,38,729 active cases and 62,27,296 recovered and discharged or migrated cases. There were 706 deaths due to the coronavirus in the last 24 hours. So far 1,09,856 people have died due to the disease.
On Sunday, Harsh Vardhan warned the people of the country to stay away from the big vegetable markets and follow the government-issued guidelines regarding precautions in view of the coming festive season. Speaking at an event on Sunday, he said that coronavirus transmission is likely to increase during the winter as it is a respiratory virus and transmission of respiratory viruses is known to increase during the cold season.
2 Doses and 3 Doses vaccines
Currently COVID-19 vaccines in India have 2 doses and 3 dose vaccines. The vaccine by the Serum Institute of India and Bharat Biotech requires 2 doses, while the Cadila Healthcare vaccine requires 3 doses. For other vaccines in preclinical stages, the dose is being tested.
Covid-19 vaccine for testing in India
Currently, one of the two indigenously developed vaccine candidates, one by Bharat Biotech with ICMR and the other by Zydus Cadila Ltd, is in Phase 2 of the human trials. The Pune-based Serum Institute of India, which has partnered with AstraZeneca to manufacture the Oxford Covid-19 vaccine, is conducting the candidate’s Phase 2 and 3 human trials in India.